Oroxylum
Evidence status
Limited evidence to recommend for any consumer outcome yet.
2 papers · 0 claims · 9 outcomes scored
Risk profile
Adverse events and known drug interactions
Safety events
digestive complaints (loose stools, nausea, bloating) mild
headache mild
skin rash
adverse effects (unspecified)
Drug interactions
Doxorubicin moderate unknown
Cyclophosphamide moderate unknown
Sources
- 1. Effects of an Oroxylum indicum Extract (Sabroxy®) on Cognitive Function in Adults With Self-reported Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Study. (2021) ↑
- 2. Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation. (2025) ↑
Generated August 14, 2026